Health Tech & Medtech · San Francisco, United States · Founded 2014
Lemonaid Health operates as a direct-to-consumer telehealth and pharmacy service, functioning as a subsidiary of 23andMe following a noteworthy acquisition. The company was established in 2013 by co-founders Paul Johnson and Ian Van Every with the objective of making healthcare more accessible and affordable across the United States. Johnson, who serves as CEO, brought a history of entrepreneurship and experience in digital retail to the venture, motivated by a personal family health incident to apply technology to traditional industries. The firm's history includes the launch of its first app for contraceptive pills in 2015 and a depression and anxiety service in 2019, treating over 145,000 patients that year.
The business model centers on a transparent, fee-for-service structure, eliminating reliance on insurance for its core services. Revenue is generated through flat fees for one-time virtual consultations and recurring monthly subscriptions for ongoing care management, such as for mental health or weight loss programs. The platform serves individuals over 18 in all 50 U.S. states, targeting consumers who seek convenient and discreet alternatives to in-person medical appointments. After a patient completes an online assessment, a team of U.S.-licensed doctors and nurse practitioners reviews the case, provides a diagnosis, and, if appropriate, issues a prescription. The company's integrated mail-order pharmacy then ships medications directly to the patient's home, typically within a few days.
Lemonaid Health's service portfolio is extensive, covering a wide range of common medical conditions. These include men's and women's health issues like erectile dysfunction and birth control, mental health services for anxiety and depression, primary care, skin conditions, and various lab testing services. A significant milestone occurred in late 2021 when 23andMe acquired Lemonaid Health for $400 million, a deal comprising 25% cash and 75% stock. This strategic acquisition was aimed at integrating Lemonaid's telemedicine and pharmacy capabilities with 23andMe's genetic data, with a shared vision of creating a personalized primary care experience where treatments are informed by genetic insights.
Keywords: telehealth, online pharmacy, virtual healthcare, prescription delivery, digital health, direct-to-consumer healthcare, telemedicine services, online doctor consultation, men's health, women's health, mental health treatment, primary care platform, 23andMe, Paul Johnson, Ian Van Every, online prescriptions, healthcare accessibility, affordable healthcare, virtual medical care, at-home lab testing, medication management, healthcare technology
Dealroom maps Lemonaid's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
19team members profilednamed & role-tagged by Dealroom
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Market sentiment
What the market is saying about Lemonaid
An AI-synthesized read of the highest-engagement posts about Lemonaid on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lemonaid on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
L
